Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer
Status:
Recruiting
Trial end date:
2025-02-23
Target enrollment:
Participant gender:
Summary
This phase IIb pilot study will enrol 20 patients (women) presenting with metastatic breast
cancer (ER/PR + HER2- on histology) who require imaging for staging or re-staging of their
disease.